Hologic hopes to enter a strategic alliance with Agfa to help develop its amorphous selenium digital mammography system. The collaboration, which could be finalized in the next several months, would leverage Agfa's strength in image processing
Hologic hopes to enter a strategic alliance with Agfa to help develop its amorphous selenium digital mammography system. The collaboration, which could be finalized in the next several months, would leverage Agfa's strength in image processing optimization and system integration. Hologic announced its intent to enter a similar alliance late last year with Siemens Medical Solutions (SCAN 12/26/01). The finished version of the digital mammography system would include PACS, data acquisition, and hard-copy readout. Hologic would manufacture systems for sale under its own label as well as that of Agfa. Hologic's alliance with Agfa, if consummated, would also provide for reciprocal distribution rights of Hologic's and Agfa's medical image management systems and workstations.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.